Invitrogen/Life Technologies (B)

On June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.

Collection: Stanford Graduate School of Business (USA)
Ref: SGSB-SM209B-E
Format: PDF
Number of pages: 4
Publication Date: Jun 20, 2012
Language: English

Description

On June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.
Read more
Year: 2012

Invitrogen/Life Technologies (B)

Options of use
Number of copies
- +
As low as €5.74

Are you interested in this product?

Add it to your favourites so that your institution can purchase it.
You'll be able to order once your profile has been validated.
Add to wishlist

Leave your rating

"Invitrogen/Life Technologies (B)"